Jump Financial »

Inhibrx Biosciences shares owned by Jump Financial

Quarter-by-quarter ownership of Inhibrx Biosciences (INBX) shares owned by Jump Financial from 13F filings

Historical chart of Jump Financial investment in Inhibrx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Inhibrx Biosciences held by Jump Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibrx Biosciences by Jump Financial

Quarter filed Position value Share count Share price at filing
2025-12-31 $277k 3.5k 79.00

More positions owned by Jump Financial

iShares Russell 2000 ETF Etf (IWM)
SPDR S&P 500 ETF Trust Etf Call Option (SPY)
iShares 20 Year Treasury Bond ETF Etf (TLT)
NVIDIA Corp Common Stock (NVDA)
Walmart Common Stock (WMT)
Amazon.com Common Stock (AMZN)
Microsoft Corp Common Stock (MSFT)
iShares iBoxx $ High Yield Corporate Bond ETF Etf (HYG)
Alphabet Common Stock (GOOGL)
Advanced Micro Devices Common Stock (AMD)
Netflix Common Stock (NFLX)
Palantir Technologies Common Stock (PLTR)
Alibaba Group Holding Convertible bond (Principal)
Boston Scientific Corp Common Stock (BSX)
Energy Transfer Partnership Shares (ET)

View all positions for Jump Financial

Top funds holding Inhibrx Biosciences

Viking Global Investors
Perceptive Advisors
Sanofi
HighTower Advisors
BlackRock
Susquehanna International
Vanguard Group
Caligan Partners
Sofinnova Ventures
Capital Research Global Investors
State Street Corporation
Millennium Management
Healthcare Of Ontario Pension Plan Trust Fund
Partner Fund Management
Geode Capital Management

View all funds holding Inhibrx Biosciences